View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200 / Doxorubicin 60 / Cyclophosphamide 600, Breast Ca, neoadjuvant, cycle 5-8
Protocol-ID: 1466 V1.1 (Mini), PEMB200/DOXO60/CYCL600, Breast Ca, neoadj., C5-8Indication(s)
- Breast Cancer (tripel negative); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 23.04.2024